Vertex Pharmaceuticals Financial Overview
Vertex Pharmaceuticals's market cap is currently €98.82B. The company's EPS TTM is €4.0982592; its P/E ratio is 30.33; Vertex Pharmaceuticals is scheduled to report earnings on November 3, 2025, and the estimated EPS forecast is €4.37. See an overview of income statement, balance sheet, and cash flow financials.
